Results 161 to 170 of about 19,509 (202)

A pilot study of re-purposing drugs to treat koalas with chlamydia. [PDF]

Sci Rep
Fleming C, Nugent H, Quinteros SL, Fernando BSM, Tyndall JDA, Webb JK, Mella VSA, Huston WM.   +7 more
europepmc   +1 more source

Role of Cardiac Magnetic Resonance (CMR) as a Diagnostic and Risk Stratification Tool for a Patient With Arrhythmic Mitral Valve Complex Phenotype and Tricuspid Annular Disjunction (TAD). [PDF]

Cureus
Raslan M, Huang XN, Elmarzouky ZM.
europepmc   +1 more source

An ominous ECG. [PDF]

Neth Heart J
Libbrecht M, De Meyer T, Boulaksil M.
europepmc   +1 more source

Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study

International Journal of Cardiology, 2022
AIMS To evaluate the role of bisoprolol to control symptoms and left ventricular outflow tract obstruction (LVOTO) in a consecutive cohort of adults with hypertrophic cardiomyopathy (HCM).
Emanuele Monda, Giuseppe Palmiero, Marta Rubino   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

Lancet, The, 1999
CIBIS-II Investigators and Committees
exaly   +2 more sources

Bisoprolol and Bisoprolol-Valsartan Compatibility Studied by Differential Scanning Calorimetry, Nuclear Magnetic Resonance and X-Ray Powder Diffractometry [PDF]

Pharmaceutical Research, 2014
Purpose The objective of this study was to evaluate the thermal behavior of crystalline and amorphous bisoprolol fumarate and its compatibility with amorphous valsartan.
Marcin Skotnicki, , Marek Pyda
exaly   +2 more sources